CEO total pay
$36,698,337
David A. Ricks · 2025
Say on pay
Not disclosed
Use Ask for the underlying narrative
CEO pay ratio
Not in CD&A
Median employee: $36,698,337
Compensation committee
CD&ACompensation Committee
Per the latest proxy
Filings indexed: 2 · 2026 · 2025
Executive pay
What did they pay them?
From the Summary Compensation Table. Pay mix and YoY are computed from these rows.
| Executive | Role | TotalYoY | Pay mix | Salary | Stock | Cash incentive | Other |
|---|---|---|---|---|---|---|---|
David A. Ricks2025 compensation | Chair, President, and Chief Executive Officer | $36,698,337↑ 25% | 91% at-risk | $1,700,000 | $23,325,000 | — | $736,201 |
Lucas Montarce2025 compensation | Executive Vice President and Chief Financial Officer | $8,483,315↑ 188% | 83% at-risk | $1,000,000 | $5,000,000 | — | $60,000 |
Daniel M. Skovronsky, M.D., Ph.D.2025 compensation | Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | $17,786,576↑ 41% | 88% at-risk | $1,490,385 | $12,000,000 | — | $159,307 |
Anat Hakim2025 compensation | Executive Vice President, General Counsel and Secretary | $9,845,518↑ 32% | 84% at-risk | $1,000,000 | $6,000,000 | — | $162,570 |
Jake Van Naarden2025 compensation | Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development | $7,586,097↑ 31% | 82% at-risk | $920,192 | $4,500,000 | — | $72,519 |
Pay mix: base cash incentive equity other
CD&A excerpt
Compensation discussion & analysis
Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.
Read the full CD&A on SEC.gov ↗
Governance
Policy guardrails
hedging
prohibited
“Prohibition on Hedging and Pledging Shares”
pledging
prohibited
“Prohibition on Hedging and Pledging Shares”
clawback
present
“Additionally, the policy allows for the recoupment of incentive compensation (cash or stock) and/or non-qualified benefits previously granted or paid to executives (including certain non-executive officers) in the event …”
stock ownership guidelines
present
“All NEOs are in compliance with the share ownership guidelines”
change in control
However, vesting does not accelerate immediately upon a change in control
“However, vesting does not accelerate immediately upon a change in control”
compensation consultant
independent
“Independent compensation consultant input”
compensation committee
Compensation Committee
“The Science & Technology Committee may recommend that the Talent & Compensation Committee apply discretion to the pipeline metric result”
Performance markers
Metric facts
revenue
$24.01
“including those disclosed in “Innovation Pipeline and Other Business Development” within the Proxy Statement Summary. The assessment resulted in a 230% pipeline bonus multiple. Strong financial performance combined with …”
median employee compensation
$36,698,337
“CEO Pay Ratio Lilly is committed to ensuring that every employee’s pay reflects their job’s impact and responsibilities and remains market competitive. As required by SEC rules, we are providing the ratio of our CEO’s an…”
Ask
Anything about ELI LILLY & Co’s 2026 proxy
Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.
Loading the Ask interface…